Soleil Securities downgrades Hologic (Nasdaq: HOLX) from Hold to Sell. Price target lowered from $13 to $11.

Soleil analyst says ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE